內地造船新接訂單量領跑全球 有船企訂單已排至2029年
據《央視》報道,在當前複雜的全球貿易形勢下,內地造船產業依舊表現出強勁的市場韌性與競爭力,走出產業加速度。中國船舶工業行業協會公布數據顯示,今年首四個月,中國造船完工量、新接訂單量和手持訂單量分別達到1,532萬載重噸、3,069萬載重噸和約2.3億載重噸,分別佔世界市場份額的49.9%、67.6%和64.3%,主要造船指標仍保持全球第一。
報道引述業內人士指出,當前全球船廠產能持續處於緊平衡狀態,存量船隊周期性更新需求釋放,造船業景氣週期仍將持續。目前不少造船企業的訂單飽滿,生產任務也排至幾年之後。更有船企表示,手持訂單170條船左右,當中以歐洲的訂單為主,訂單甚至已排到2029年。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.